U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06886061) titled 'Effect of Continuous Intake of Ergothioneine-containing Supplements on Skin Condition' on March 03.
Brief Summary: This trial employed a non-randomized, double-blind, placebo-controlled design to evaluate the effects of DR. ERGO(R) Capsules (each containing 30mg of ergothioneine) on the skin condition of women aged 35 to 59 after continuous daily intake for 8 weeks. The trial assessed skin condition across multiple dimensions, including brightness, color tone, melanin, erythema, gloss, elasticity, and spots, using various instruments and questionnaire surveys. Additionally, safety was monitored through daily log records and safety ...